Assessment of genomic instability using the CBMN cytome assay in mother-newborn pairs prenatally exposed to pesticides in Colombia Authors: Shirley Salcedo Arteaga, Ana Peñata Taborda, Sara Soto De Leon, Dina Ricardo Caldera, Ana Carolina Negrete, Lavínia Schüler-Faccini Published: 2026 ABSTRACT Agricultural communities in northern Colombia face high exposure to pesticides, posing significant health risks, particularly to vulnerable populations such as pregnant women and their developing fetuses. The genotoxic impact of in utero pesticide exposure remains poorly understood in this region. To assess the association between residential prenatal pesticide exposure and genomic instability in mother-newborn pairs from a rural agricultural area in Córdoba, Colombia. A case-control study was conducted with 86 mother-newborn pairs (45 exposed, 41 non-exposed). Sociodemographic and exposure data were collected via structured questionnaires. Genomic instability was evaluated in peripheral and umbilical cord blood lymphocytes using the comprehensive Cytokinesis-Block Micronucleus (CBMN) Cytome assay. A statistically significant increase in the frequency of micronucleated binucleated cells (MNBN) was observed in both mothers and newborns from the exposed group compared to the reference group (p < 0.05). Newborns in the exposed area showed a five-fold higher prevalence of elevated MNBN frequencies (PR = 5.15; 95% CI: 2.42–10.97, p < 0.0001), confirming a strong association with residential pesticide exposure. Prenatal exposure to pesticides is strongly associated with increased genomic instability in newborns, suggesting the hypothesis of transplacental transfer of genotoxic agents or their metabolites, though shared environmental exposures cannot be ruled out. These findings highlight a critical public health issue and underscore the need for protective policies to mitigate pesticide exposure in pregnant women in agricultural regions. Introduction Pesticides are fundamental elements of contemporary agricultural practices. Their application brings immediate benefits in terms of the quality and quantity of food production, thus contributing to improving the economic prosperity and well-being of nations. However, their widespread use often overlooks the risks they pose to the biosphere [1]. Pesticides are a family of compounds that have brought many benefits to mankind in the agricultural, industrial and health fields, although their toxicity in both humans and animals has always been a cause for concern. They can trigger oxidative stress within living organisms, which is the focal point for triggering apoptosis, developmental abnormalities and tissue death in living things [1]. In general, organophosphates (OPs) are neurotoxic due to their inhibitory action on acetylcholinesterase (AChE) through phosphorylation of this enzyme. The characteristic signs and symptoms of acute organophosphate poisoning mostly result in cholinergic crisis. Chronic exposure to organophosphates can lead to nausea, headaches, and mental confusion [2]. Evidence suggests that OPs negatively interfere with fetal growth and development when exposure occurs before birth. Neonate survival is compromised in populations exposed to pesticides compared to unexposed populations, with higher risk of spontaneous abortions, intrauterine growth restriction and premature births in pregnant women exposed to OP pesticides. Intellectual and neurodevelopmental adverse outcomes have also been associated with prenatal OP exposures. Its effect on placentation remains controversial; while some studies show pesticides can induce oxidative stress, alter placental angiogenesis, or inhibit enzymes like acetylcholinesterase in placental tissue, other studies report adaptive placental responses or a lack of significant morphological changes at low doses [3], [4]. Epidemiological and environmental studies support the direct link between the mass use of pesticides and the presence of adverse effects on the environment and human health that include an increase in the morbidity of diseases and cancer. Children constitute one of the most vulnerable groups to environmental exposure to pesticides. On the one hand, their immune system is still developing, so their enzymatic and metabolic systems may be less able to detoxify and excrete [5], [6]. Exposure during pregnancy can be particularly harmful to both the mother and the developing fetus, which is especially sensitive to environmental contaminants. In fact, critical developmental windows have been identified in which exposure to these chemicals could lead to impaired fetal growth [7], [8], [9]. Fetal growth is often assessed using indirect measures such as newborn weight, height, and gestational length, which are also risk factors for future morbidity during childhood and adulthood and irreversible pathological changes in adult life. Possible mechanisms of action for fetal growth disruption could include the ability of these compounds to interfere with estrogen and androgen homeostasis and even thyroid function [10]. Materials and methods Study design and population A case-control study was conducted in the Colombian Caribbean region, specifically in the municipality of Santa Cruz de Lorica, Córdoba department. The study area was selected based on intensive agricultural activity and documented pesticide use. According to data from the Colombian Agricultural Institute (ICA), organochlorines, organophosphates, and pyrethroids are among the most heavily commercialized and applied pesticide active ingredients in the Córdoba department, providing a strong context for the expected exposure profile in Santa Cruz de Lorica. The study population consisted of 86 mother-newborn pairs: 45 pairs from the exposure zone (Lorica) and 41 pairs from the reference zone (Montería), located in the northern part of the Colombian Caribbean Coast. The exposure zone is characterized by intensive agricultural activity with documented pesticide application, while the reference zone consists of an urban area with minimal agricultural activity Fig. 1.Fig. 1Areas of study in Colombia. Areas of study in Colombia. Inclusion and exclusion criteria Participants were included in the study if they met the following criteria: (1) mothers aged ≥ 14 and ≤ 39 years old; (2) singleton pregnancies; (3) delivery at term (≥37 weeks gestation); (4) absence of maternal complications during pregnancy; (5) healthy newborns with Apgar scores ≥ 8 at 5 min; and (6) willingness to participate and provide informed consent. Exclusion criteria included: (1) maternal history of chronic disease; (2) use of medications during pregnancy; (3) maternal smoking; (4) alcohol consumption during pregnancy; (5) previous exposure to known teratogens; and (6) newborns with congenital anomalies or chromosomal abnormalities. Data collection Sociodemographic data and information on pesticide exposure were collected using a structured questionnaire administered by trained personnel during hospital interviews. The questionnaire applied was based on the one used by De Roos et al. according to the Agricultural Health Study (AHS) available on the NIH website in the United States [11]. Questions addressed residential proximity to agricultural pesticide application, occupational exposure, dietary habits, smoking exposure, and use of vitamins and supplements. Cytogenetic assay Genomic instability was evaluated using the comprehensive Cytokinesis-Block Micronucleus (CBMN) Cytome assay as described by Fenech [12], [13]. Peripheral blood samples from mothers were collected in heparinized tubes, and umbilical cord blood samples were collected from newborns immediately after delivery. Lymphocytes were isolated using density gradient centrifugation and cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum, 2 mM L-glutamine, and antibiotics. Cultures were stimulated with phytohemagglutinin (PHA) for 44 h, and then cytochalasin B was added to block cytokinesis. Cells were harvested after 72 h of culture, fixed, and stained with Giemsa. Slides were coded and analyzed blind by trained personnel. For each individual, 1000 binucleated cells were scored for the presence of micronuclei (MN), nucleoplasmic bridges (NBUD), and other cytogenetic parameters. Statistical analysis Descriptive statistics were calculated for all variables. The Mann-Whitney U test was used to compare cytogenetic parameters between exposed and reference groups. Pearson correlation coefficients were calculated to assess the relationship between maternal and newborn cytogenetic parameters. Poisson regression analysis was performed to identify independent risk factors for increased MNBN frequency. A p-value < 0.05 was considered statistically significant. Ethical considerations The study was approved by the Institutional Review Board (IRB) of the Universidad del Sinú. All participants provided written informed consent before enrollment. The study was conducted in accordance with the Declaration of Helsinki and Colombian regulations for human research. Results Sociodemographic characteristics The sociodemographic characteristics of the individuals studied are shown in Table 1. The total population consisted of 86 individuals who met the inclusion criteria and voluntarily participated in the study, comprising 45 mothers with their 45 newborns in the exposure zone (Lorica) and 41 mothers with their 41 newborns in the reference zone in Montería. While the samples were similar in most sociodemographic characteristics, it is important to acknowledge that the reference group (university professors and office workers) may differ in other lifestyle factors such as occupational stress, sedentary behavior, diet, and urban air pollution, which could potentially act as unmeasured confounders influencing genomic stability.Table 1Main Clinical Characteristics and Lifestyle of the Study Population.Independent variablesExposedNon-exposedp-valueAge Mothers (Median ± SD)24.3 ± 6.123.2 ± 5.30.7< 35 old years37 (90.2)43 (34.4)> 35 old years4 (9.8)2 (65.6)Intake habits (%)CoffeeYes28 (46.7)32 (53.3)No13(53.3)13 (50.0)Lives with someone who smokesYes8 (44.0)10 (48.5)No33 (56.0)35 (51.5)Maternal exposureTime exposure (Mean ± SD)9.4 ± 8.413.9 ± 10.40.12Exposure type (%)Residential26 ( 63.4)0Direct4 (9.7)0Indirect11(26.8)0Spouse's occupation (%)Farmer11 (26.8)14 (31.1)Other30 (73.2)31 (68.9)Pregnancy number (Median ± SD)2.0 ± 1.02.0 ± 1.00.25Vitamins and supplements (%)Yes36 (87.8)35 (85.4)No5 (12.2)10 (28.4)Previous abortion/stillbirth (%)9 (4.05)6 (2.46)0.28High blood pressure (%)6 (2.46)7 (3.15)Neonatal dataSexFemale21 (51.22)27 (60.0)Male20 (48.78)18 (40.0)Type of birth (%)Vaginal delivery10 (76.9)3 (23.1)C-section35 (47.9)38 (52.1)Birth weight (Median ± SD)3089.0 ± 449.52950.4 ± 233.90.12Low4 (57.1)3 (42.9)Normal34 (44.7)42 (55.3)Higher3 (100)0 (0)Gestational age (Median ± SD)37.7 ± 1.437.8 ± 2.70.05< 37 weeks8 (57.1)6 (42.9)> 37 weeks26 (40)39 (60)Note: Values are presented as n (%) for categorical variables or Median ± SD for continuous variables. Table 1Main Clinical Characteristics and Lifestyle of the Study Population.Independent variablesExposedNon-exposedp-valueAge Mothers (Median ± SD)24.3 ± 6.123.2 ± 5.30.7< 35 old years37 (90.2)43 (34.4)> 35 old years4 (9.8)2 (65.6)Intake habits (%)CoffeeYes28 (46.7)32 (53.3)No13(53.3)13 (50.0)Lives with someone who smokesYes8 (44.0)10 (48.5)No33 (56.0)35 (51.5)Maternal exposureTime exposure (Mean ± SD)9.4 ± 8.413.9 ± 10.40.12Exposure type (%)Residential26 ( 63.4)0Direct4 (9.7)0Indirect11(26.8)0Spouse's occupation (%)Farmer11 (26.8)14 (31.1)Other30 (73.2)31 (68.9)Pregnancy number (Median ± SD)2.0 ± 1.02.0 ± 1.00.25Vitamins and supplements (%)Yes36 (87.8)35 (85.4)No5 (12.2)10 (28.4)Previous abortion/stillbirth (%)9 (4.05)6 (2.46)0.28High blood pressure (%)6 (2.46)7 (3.15)Neonatal dataSexFemale21 (51.22)27 (60.0)Male20 (48.78)18 (40.0)Type of birth (%)Vaginal delivery10 (76.9)3 (23.1)C-section35 (47.9)38 (52.1)Birth weight (Median ± SD)3089.0 ± 449.52950.4 ± 233.90.12Low4 (57.1)3 (42.9)Normal34 (44.7)42 (55.3)Higher3 (100)0 (0)Gestational age (Median ± SD)37.7 ± 1.437.8 ± 2.70.05< 37 weeks8 (57.1)6 (42.9)> 37 weeks26 (40)39 (60)Note: Values are presented as n (%) for categorical variables or Median ± SD for continuous variables. Main Clinical Characteristics and Lifestyle of the Study Population. Note: Values are presented as n (%) for categorical variables or Median ± SD for continuous variables. Mean maternal age was 24.3 years ± 6.0 (range 18–39 years) in the exposed group and 23.2 years ± 5.2 (range 14–35 years) in the reference group. Notably, the inclusion of adolescent mothers indicates that this demographic constitutes a relevant part of the studied population. Age stratification revealed important differences between groups: in the exposed group, 0 mothers were < 18 years old (0%), 37 were 18–35 years old (90.2%), and 4 were > 35 years old (9.8%). In the reference group, 8 mothers were < 18 years old (17.8%), 37 were 18–35 years old (82.2%), and 0 were > 35 years old (0%). Overall, 8 adolescent mothers (<18 years) participated in the study, representing 9.3% of the total population Table 2.Table 2Age Stratification of Maternal Population.Age GroupExposed (n = 41)Reference (n = 45)Total (n = 86)< 18 years0 (0%)8 (17.8%)8 (9.3%)18–35 years37 (90.2%)37 (82.2%)74 (86.0%)> 35 years4 (9.8%)0 (0%)4 (4.7%)Note: This table shows the age stratification of maternal population in both exposed and reference groups. The exposed group had no adolescent mothers (<18 years), while the reference group included 8 adolescent mothers (17.8%), representing an important demographic difference between groups. Table 2Age Stratification of Maternal Population.Age GroupExposed (n = 41)Reference (n = 45)Total (n = 86)< 18 years0 (0%)8 (17.8%)8 (9.3%)18–35 years37 (90.2%)37 (82.2%)74 (86.0%)> 35 years4 (9.8%)0 (0%)4 (4.7%)Note: This table shows the age stratification of maternal population in both exposed and reference groups. The exposed group had no adolescent mothers (<18 years), while the reference group included 8 adolescent mothers (17.8%), representing an important demographic difference between groups. Age Stratification of Maternal Population. Note: This table shows the age stratification of maternal population in both exposed and reference groups. The exposed group had no adolescent mothers (<18 years), while the reference group included 8 adolescent mothers (17.8%), representing an important demographic difference between groups. In the exposed group, 100% had residential exposure, some with work related to exposure or with indirect exposure due to their spouse's occupational activities. Although participating mothers reported not being smokers, 8 (19.5%) of the exposed and 10 (24.3%) of the reference group reported living with smokers. Intake of vitamins and supplements was reported by 88% of the exposed and 77% in the reference group. Cytogenetic event frequencies Significant differences were found in DNA damage by the Cytome assay between the exposed and reference mothers and their newborns Fig. 2.Fig. 2Comparison of micronucleated binucleated cell (MNBN) frequencies between exposed and reference groups. The bar chart shows the mean frequency (± SEM) of MNBN per 1000 cells in mothers and newborns. A statistically significant increase was observed in the exposed group for both mothers and newborns compared to their respective reference groups. (***p < 0.001, Mann-Whitney U test). Comparison of micronucleated binucleated cell (MNBN) frequencies between exposed and reference groups. The bar chart shows the mean frequency (± SEM) of MNBN per 1000 cells in mothers and newborns. A statistically significant increase was observed in the exposed group for both mothers and newborns compared to their respective reference groups. (***p < 0.001, Mann-Whitney U test). The cytogenetic parameters measured by the Cytome assay demonstrated a significant increase in the frequency of micronucleated binucleated cells (MNBN), nucleoplasmic bridges (NBUD), and mononucleated cells among mothers and children in the exposed group compared to those in the reference area (p < 0.05). Table 3 presents the detailed results.Table 3Distribution of Cytogenic Event Frequencies in Maternal and Cord Blood.Cytome assay parametersExposedReferenceMothersNewbornsMothersNewbornsDNA damage indices in BN cellsMean ± SDMean ± SDSpearman's correlation ( P value)Mean ± SDMean ± SDSpearman's correlation (P value)MNBN1.63 ± 1.651.43 ± 1.380,0276*0.42 ± 0.810.49 ± 1.040,9866NPB1.02 ± 1.291.75 ± 2.090,0013**0.40 ± 0.690.46 ± 1.850,5995NBUDS1.26 ± 1.591.61 ± 1.700,0002***0.46 ± 0.690.53 ± 1.050,9064Cytostatic events and cell deathNECR2.24 ± 1.882.58 ± 1.670,0093**2.02 ± 2.701.73 ± 3.040,0062**APOP0.87 ± 2.360.87 ± 2.460,0016**0.66 ± 1.690.82 ± 2.370,0545MONO121.10 ± 48.03156.60 ± 40.000,0238*83.53 ± 55.9122.0 ± 72.540,0039**MULTI116.90 ± 40.9583.12 ± 31.300,0378*114.6 ± 75.6161.84 ± 51.410,4254NDI1.98 ± 0.181.84 ± 0.130,0351*1.95 ± 0.481.70 ± 0.460,8501Note: MNBN = Micronucleated Binucleated; NPB = Nucleoplasmic Bridges; NBUDS = Nuclear Buds; NECR = Necrotic; APOP = Apoptotic; MONO = Mononucleated; MULTI = Multinucleated; NDI = Nuclear Division Index. *p < 0.05; **p < 0.01; ***p < 0.001. Values in bold indicate statistical significance (p < 0.05). Table 3Distribution of Cytogenic Event Frequencies in Maternal and Cord Blood.Cytome assay parametersExposedReferenceMothersNewbornsMothersNewbornsDNA damage indices in BN cellsMean ± SDMean ± SDSpearman's correlation ( P value)Mean ± SDMean ± SDSpearman's correlation (P value)MNBN1.63 ± 1.651.43 ± 1.380,0276*0.42 ± 0.810.49 ± 1.040,9866NPB1.02 ± 1.291.75 ± 2.090,0013**0.40 ± 0.690.46 ± 1.850,5995NBUDS1.26 ± 1.591.61 ± 1.700,0002***0.46 ± 0.690.53 ± 1.050,9064Cytostatic events and cell deathNECR2.24 ± 1.882.58 ± 1.670,0093**2.02 ± 2.701.73 ± 3.040,0062**APOP0.87 ± 2.360.87 ± 2.460,0016**0.66 ± 1.690.82 ± 2.370,0545MONO121.10 ± 48.03156.60 ± 40.000,0238*83.53 ± 55.9122.0 ± 72.540,0039**MULTI116.90 ± 40.9583.12 ± 31.300,0378*114.6 ± 75.6161.84 ± 51.410,4254NDI1.98 ± 0.181.84 ± 0.130,0351*1.95 ± 0.481.70 ± 0.460,8501Note: MNBN = Micronucleated Binucleated; NPB = Nucleoplasmic Bridges; NBUDS = Nuclear Buds; NECR = Necrotic; APOP = Apoptotic; MONO = Mononucleated; MULTI = Multinucleated; NDI = Nuclear Division Index. *p < 0.05; **p < 0.01; ***p < 0.001. Values in bold indicate statistical significance (p < 0.05). Distribution of Cytogenic Event Frequencies in Maternal and Cord Blood. Note: MNBN = Micronucleated Binucleated; NPB = Nucleoplasmic Bridges; NBUDS = Nuclear Buds; NECR = Necrotic; APOP = Apoptotic; MONO = Mononucleated; MULTI = Multinucleated; NDI = Nuclear Division Index. *p < 0.05; **p < 0.01; ***p < 0.001. Values in bold indicate statistical significance (p < 0.05). There was a significant correlation between mothers and newborns within the same area, and all cytogenetic parameters showed a significant correlation between mothers and newborns in the exposed area. In the reference area, only necrosis (r = 0.402, p = 0.0062) and mononuclear cell events (r = 0.421, p = 0.0039) demonstrated significant correlations, Table 4 and Fig. 3.Table 4Correlation Between Pesticide and Cytome Assay Parameters for Exposed Population.Correlation between pesticide and cytome assayCytome assay parametersAldrinDiedrinCypermethrinRound_brioGlyphosateGramoxol_slDimetox_40ecAmina_6Lorsban_4cRegent_200MothersMONO0,190−0,005−0,0910,032−0,010−0,012−0,1680,020−0,0700,214BN−0,0360,063−0,166−0,245−0,2680,020−0,220−0,3650,0980,214MULT−0,1590,1100,108−0,0160,132−0,0700,2490,0960,005−0,254APOT−0,104−0,1270,0760,0950,0000,093−0,127−0,232−0,3400,222NEC−0,155−0,261−0,0370,0040,0070,2300,2210,1400,1760,240MNBN−0,1500,082−0,044−0,204−0,1970,005−0,192−0,3510,141−0,055NPB0,178−0,006−0,130−0,141−0,0980,049−0,0670,0950,141−0,145NBUDS−0,0720,046−0,031−0,029−0,2250,127−0,223−0,1140,200−0,156NewbornsMONO−0,0550,0710,048−0,1540,2220,329−0,2540,0380,0190,227BN0,062−0,0600,074−0,131−0,184−0,095−0,0430,0850,1090,074MULT−0,0810,030−0,1300,249−0,198−0,3360,316−0,120−0,074−0,241APOT−0,060−0,0670,128−0,1370,0700,310−0,111−0,038−0,0500,300NEC0,103−0,3200,0540,121−0,0490,2580,1310,0770,135−0,156MNBN0,145−0,071−0,310−0,016−0,4170,021−0,287−0,314−0,0380,111NPB0,4290,068−0,194−0,094−0,050−0,212−0,129−0,121−0,191−0,173NBUDS0,327−0,065−0,107−0,111−0,202−0,103−0,139−0,2540,104−0,173Bold text indicates statistically significant (values P < 0.005).MONO= mononucleated; BN= binucleated; MULT= multinucleated; APOT= apoptotic; NEC=necrotic; MNBN=micronucleus in binucleated; NPB= nucleoplasmic bridge; NBUDS= Nuclear outbreak.Note: Values represent Pearson correlation coefficients between specific pesticides and cytome assay parameters. Bold text indicates correlations ≥ |0.30|. MONO = Mononucleated; BN = Binucleated; MULT = Multinucleated; APOT = Apoptotic; NEC = Necrotic; MNBN = Micronucleated Binucleated; NPB = Nucleoplasmic Bridges; NBUDS = Nuclear Buds.Fig. 3Correlation of MNBN frequencies between mothers and their newborns. Scatter plot showing the positive correlation between maternal and newborn MNBN frequencies in both exposed (red) and reference (blue) groups. The correlation was stronger in the exposed group (r = 0.58, p < 0.001 for exposed group; r = 0.35, p < 0.05 for reference group, p < 0.001) compared to the reference group (r = 0.58, p < 0.001 for exposed group; r = 0.35, p < 0.05 for reference group, p < 0.01), suggesting a shared genomic response to environmental exposure. Table 4Correlation Between Pesticide and Cytome Assay Parameters for Exposed Population.Correlation between pesticide and cytome assayCytome assay parametersAldrinDiedrinCypermethrinRound_brioGlyphosateGramoxol_slDimetox_40ecAmina_6Lorsban_4cRegent_200MothersMONO0,190−0,005−0,0910,032−0,010−0,012−0,1680,020−0,0700,214BN−0,0360,063−0,166−0,245−0,2680,020−0,220−0,3650,0980,214MULT−0,1590,1100,108−0,0160,132−0,0700,2490,0960,005−0,254APOT−0,104−0,1270,0760,0950,0000,093−0,127−0,232−0,3400,222NEC−0,155−0,261−0,0370,0040,0070,2300,2210,1400,1760,240MNBN−0,1500,082−0,044−0,204−0,1970,005−0,192−0,3510,141−0,055NPB0,178−0,006−0,130−0,141−0,0980,049−0,0670,0950,141−0,145NBUDS−0,0720,046−0,031−0,029−0,2250,127−0,223−0,1140,200−0,156NewbornsMONO−0,0550,0710,048−0,1540,2220,329−0,2540,0380,0190,227BN0,062−0,0600,074−0,131−0,184−0,095−0,0430,0850,1090,074MULT−0,0810,030−0,1300,249−0,198−0,3360,316−0,120−0,074−0,241APOT−0,060−0,0670,128−0,1370,0700,310−0,111−0,038−0,0500,300NEC0,103−0,3200,0540,121−0,0490,2580,1310,0770,135−0,156MNBN0,145−0,071−0,310−0,016−0,4170,021−0,287−0,314−0,0380,111NPB0,4290,068−0,194−0,094−0,050−0,212−0,129−0,121−0,191−0,173NBUDS0,327−0,065−0,107−0,111−0,202−0,103−0,139−0,2540,104−0,173Bold text indicates statistically significant (values P < 0.005).MONO= mononucleated; BN= binucleated; MULT= multinucleated; APOT= apoptotic; NEC=necrotic; MNBN=micronucleus in binucleated; NPB= nucleoplasmic bridge; NBUDS= Nuclear outbreak.Note: Values represent Pearson correlation coefficients between specific pesticides and cytome assay parameters. Bold text indicates correlations ≥ |0.30|. MONO = Mononucleated; BN = Binucleated; MULT = Multinucleated; APOT = Apoptotic; NEC = Necrotic; MNBN = Micronucleated Binucleated; NPB = Nucleoplasmic Bridges; NBUDS = Nuclear Buds. Correlation Between Pesticide and Cytome Assay Parameters for Exposed Population. Bold text indicates statistically significant (values P < 0.005). MONO= mononucleated; BN= binucleated; MULT= multinucleated; APOT= apoptotic; NEC=necrotic; MNBN=micronucleus in binucleated; NPB= nucleoplasmic bridge; NBUDS= Nuclear outbreak.Note: Values represent Pearson correlation coefficients between specific pesticides and cytome assay parameters. Bold text indicates correlations ≥ |0.30|. MONO = Mononucleated; BN = Binucleated; MULT = Multinucleated; APOT = Apoptotic; NEC = Necrotic; MNBN = Micronucleated Binucleated; NPB = Nucleoplasmic Bridges; NBUDS = Nuclear Buds. Correlation of MNBN frequencies between mothers and their newborns. Scatter plot showing the positive correlation between maternal and newborn MNBN frequencies in both exposed (red) and reference (blue) groups. The correlation was stronger in the exposed group (r = 0.58, p < 0.001 for exposed group; r = 0.35, p < 0.05 for reference group, p < 0.001) compared to the reference group (r = 0.58, p < 0.001 for exposed group; r = 0.35, p < 0.05 for reference group, p < 0.01), suggesting a shared genomic response to environmental exposure. Pesticide Category and Cytogenetic Abnormalities In this study, mothers residing within the exposure zone provided self-reports regarding their pesticide usage during pregnancy. Among these respondents, 76% acknowledged using organochlorine pesticides, 15% used organophosphates, and 9% used pyrethroids. The high prevalence of organochlorine use is particularly concerning due to their high lipophilicity and environmental persistence, leading to significant bioaccumulation in maternal adipose tissue and subsequent mobilization during pregnancy, contrasting with the shorter half-lives but acute toxicity of organophosphates and pyrethroids. Table 5 presents the distribution of pesticide use.Table 5Frequency and Percentage of Pesticide Groups Used by Mothers During Pregnancy (n = 41).Pesticide Groupn%OrganochlorinesAldrin819.5%Dieldrin717.1%Gramoxol_sl922.0%Amina_6614.6%Regent_20012.4%Subtotal Organochlorines3175.6%OrganophosphatesRound_brio37.3%Lorsban_4c24.9%Dimetox_40ec1126.8%Glyphosate49.8%Subtotal Organophosphates2048.8%PyrethroidsCipermethrin1024.4%Subtotal Pyrethroids1024.4%TOTAL41100.0%Note: Some mothers reported exposure to multiple pesticide groups. Percentages reflect the proportion of exposed mothers reporting use of each pesticide or group. Table 5Frequency and Percentage of Pesticide Groups Used by Mothers During Pregnancy (n = 41).Pesticide Groupn%OrganochlorinesAldrin819.5%Dieldrin717.1%Gramoxol_sl922.0%Amina_6614.6%Regent_20012.4%Subtotal Organochlorines3175.6%OrganophosphatesRound_brio37.3%Lorsban_4c24.9%Dimetox_40ec1126.8%Glyphosate49.8%Subtotal Organophosphates2048.8%PyrethroidsCipermethrin1024.4%Subtotal Pyrethroids1024.4%TOTAL41100.0%Note: Some mothers reported exposure to multiple pesticide groups. Percentages reflect the proportion of exposed mothers reporting use of each pesticide or group. Frequency and Percentage of Pesticide Groups Used by Mothers During Pregnancy (n = 41). Note: Some mothers reported exposure to multiple pesticide groups. Percentages reflect the proportion of exposed mothers reporting use of each pesticide or group. A detailed analysis of the association between specific pesticide categories and cytogenetic abnormalities is presented in Table 6.Table 6Multivariate Poisson Regression Model for MNBN in Exposed and Reference Groups.Variables Modulating MNBN FrequencyControlExposureTotalPRIC 2.5%−97.5%p-valuePRIC 2.5%- 97.5%p-valuePRIC 2.5%- 97.5%p-valueIntercept38.0382.564–5.6440.0200.5880.063–5.5200.6420.2160.001 – 45.7130.575Classification_Exposed5.1552.421 – 10.9750.000Sum_of_pesticides0.6050.388–0.9410.026Gestational_age1.0220.895 – 1.1680.745Maternal_age1.0991.019–1.1850.0141.0160.963–1.0730.5581.0611.016–1.1070,007Sum_of_symptoms1.0940–867–1.3800.449Arterial_pressure2.8191.077–7.3790.0350.8750.389 – 1.9710.748Number_of_EMB_deliveries0.6530.326–1.3100.2311.0950.749–1.6000.6400.8150.587–1.1310.220Birth_weight0.9970.995–0.9990.0011.0001.000–1.0010.6241.0000.999–1.0000.177Note: PR = Prevalence Ratio; IC = Confidence Interval. *p < 0.05; **p < 0.01. Values in bold indicate statistical significance. The exposed group shows a 5.15-fold higher prevalence ratio (PR = 5.15; 95% CI: 2.421–10.975; p = 0.0001) for elevated MNBN frequencies compared to the reference group. Table 6Multivariate Poisson Regression Model for MNBN in Exposed and Reference Groups.Variables Modulating MNBN FrequencyControlExposureTotalPRIC 2.5%−97.5%p-valuePRIC 2.5%- 97.5%p-valuePRIC 2.5%- 97.5%p-valueIntercept38.0382.564–5.6440.0200.5880.063–5.5200.6420.2160.001 – 45.7130.575Classification_Exposed5.1552.421 – 10.9750.000Sum_of_pesticides0.6050.388–0.9410.026Gestational_age1.0220.895 – 1.1680.745Maternal_age1.0991.019–1.1850.0141.0160.963–1.0730.5581.0611.016–1.1070,007Sum_of_symptoms1.0940–867–1.3800.449Arterial_pressure2.8191.077–7.3790.0350.8750.389 – 1.9710.748Number_of_EMB_deliveries0.6530.326–1.3100.2311.0950.749–1.6000.6400.8150.587–1.1310.220Birth_weight0.9970.995–0.9990.0011.0001.000–1.0010.6241.0000.999–1.0000.177Note: PR = Prevalence Ratio; IC = Confidence Interval. *p < 0.05; **p < 0.01. Values in bold indicate statistical significance. The exposed group shows a 5.15-fold higher prevalence ratio (PR = 5.15; 95% CI: 2.421–10.975; p = 0.0001) for elevated MNBN frequencies compared to the reference group. Multivariate Poisson Regression Model for MNBN in Exposed and Reference Groups. Note: PR = Prevalence Ratio; IC = Confidence Interval. *p < 0.05; **p < 0.01. Values in bold indicate statistical significance. The exposed group shows a 5.15-fold higher prevalence ratio (PR = 5.15; 95% CI: 2.421–10.975; p = 0.0001) for elevated MNBN frequencies compared to the reference group. Discussion Overview of findings This study provides compelling evidence of the genotoxic impact of prenatal pesticide exposure in a rural Colombian population [14]. The primary finding is the significantly increased frequency of micronuclei in both mothers and newborns from the exposed area compared to the reference area, confirming our initial hypothesis. This observation is consistent with a growing body of literature indicating that pesticides can induce genomic instability in exposed populations [15], [16].Table 7Summary of Known Genotoxic Profiles of Common Pesticides Used in the Study Area.Pesticide GroupSpecific CompoundsKnown Genotoxicity (ATSDR/IARC)Evidence LevelOrganochlorinesAldrinNot considered directly genotoxic; metabolized to Dieldrin [17]Low/NegativeOrganochlorinesDieldrinEvidence suggests positive genotoxicity; causes oxidative stress and DNA damage [18]Moderate/PositiveOrganophosphatesChlorpyrifos, MalathionIndirect genotoxicity through oxidative stress; not direct DNA damaging agents [19]ModeratePyrethroidsCypermethrin, DeltamethrinMixed evidence; genotoxicity mainly at high doses; limited direct DNA damage [20]Low to ModerateNote: This table provides biological context for the observed genomic instability. The high prevalence of organochlorine use (75.6% of exposed mothers) is particularly significant given the moderate to positive evidence for genotoxicity of Dieldrin, the primary metabolite of Aldrin. ATSDR = Agency for Toxic Substances and Disease Registry; IARC = International Agency for Research on Cancer. Table 7Summary of Known Genotoxic Profiles of Common Pesticides Used in the Study Area.Pesticide GroupSpecific CompoundsKnown Genotoxicity (ATSDR/IARC)Evidence LevelOrganochlorinesAldrinNot considered directly genotoxic; metabolized to Dieldrin [17]Low/NegativeOrganochlorinesDieldrinEvidence suggests positive genotoxicity; causes oxidative stress and DNA damage [18]Moderate/PositiveOrganophosphatesChlorpyrifos, MalathionIndirect genotoxicity through oxidative stress; not direct DNA damaging agents [19]ModeratePyrethroidsCypermethrin, DeltamethrinMixed evidence; genotoxicity mainly at high doses; limited direct DNA damage [20]Low to ModerateNote: This table provides biological context for the observed genomic instability. The high prevalence of organochlorine use (75.6% of exposed mothers) is particularly significant given the moderate to positive evidence for genotoxicity of Dieldrin, the primary metabolite of Aldrin. ATSDR = Agency for Toxic Substances and Disease Registry; IARC = International Agency for Research on Cancer. Summary of Known Genotoxic Profiles of Common Pesticides Used in the Study Area. Note: This table provides biological context for the observed genomic instability. The high prevalence of organochlorine use (75.6% of exposed mothers) is particularly significant given the moderate to positive evidence for genotoxicity of Dieldrin, the primary metabolite of Aldrin. ATSDR = Agency for Toxic Substances and Disease Registry; IARC = International Agency for Research on Cancer. Genotoxicity of pesticides This table provides biological context for the observed genomic instability, demonstrating that the pesticides identified in the study area have documented genotoxic potential. The high prevalence of organochlorine use (76% of exposed mothers) is particularly significant given the moderate to positive evidence for genotoxicity of Dieldrin, the primary metabolite of Aldrin. Transplacental transfer hypothesis The strong positive correlation between maternal and newborn MNBN frequencies in the exposed group (r = 0.58, p < 0.001) supports the hypothesis of transplacental transfer of genotoxic agents or their metabolites [21]. However, given the cross-sectional design and lack of direct chemical biomonitoring, we cannot entirely rule out the influence of shared environmental exposures or other unmeasured confounding factors. Maternal age as a risk factor The observation that maternal age is an independent risk factor for increased MNBN frequency is complex. On one hand, it is consistent with the well-established phenomenon of age-related accumulation of DNA damage and decline in repair capacity [22] as a proxy for cumulative environmental exposure. Notably, the exposed group had no adolescent mothers (<18 years), while the reference group included 8 adolescents (17.8%), which may have influenced the observed age-related patterns. On the other hand, the presence of adolescent mothers in the reference group introduces another biological variable, as their physiological immaturity and potential nutritional deficits might influence genomic stability and fetal development independently or synergistically with other environmental factors. Comparison with previous studies Our results are in line with previous studies. For instance, a study in Argentina reported similar findings in newborns from agricultural areas with pesticide exposure [23]. However, our study is unique in its focus on a Colombian population and its comprehensive assessment of both maternal and newborn genomic instability using the CBMN Cytome assay. [24] Limitations Several limitations of this study should be acknowledged. First, the cross-sectional design does not allow for the establishment of causality. Second, the reliance on self-reported exposure data may introduce recall bias, although we used a standardized questionnaire previously validated in similar populations [11]. We did not control for several confounding factors, residual confounding from unmeasured variables, such as specific dietary patterns related to metabolic metabolism, cannot be entirely ruled out [25], [26]. Finally, while we controlled for several confounding factors, the relatively small sample size limits the statistical power for some subgroup analyses. Conclusion In conclusion, this study demonstrates an association between self-reported residential proximity to agricultural pesticide application and increased frequencies of biomarkers of genomic instability in mother-newborn pairs in a rural Colombian population. While our findings are preliminary and limited by the small sample size, reliance on self-reported exposure, and lack of direct chemical biomonitoring, they strongly warrant further robust epidemiological and toxicological investigations. These findings emphasize the urgent need for specific interventions, such as targeted educational programs for rural communities regarding safe pesticide handling, minimizing domestic exposure (e.g., washing contaminated clothing separately), and raising awareness about the risks of pesticide drift during pregnancy [27]. Public health policies should prioritize the protection of pregnant women in agricultural regions through regulatory measures, occupational health surveillance, and community-based prevention programs. CRediT authorship contribution statement Shirley Salcedo Arteaga: Writing – original draft, Supervision, Methodology, Investigation, Formal analysis. Sara Soto De Leon: Software, Investigation. Ana Peñata Taborda: Methodology. Ana Carolina Negrete: Methodology. Lavínia Schüler-Faccini: Visualization, Validation, Formal analysis. Dina Ricardo Caldera: Methodology. Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.